Symptom-based Rehabilitation Compared to Usual Care in Post-COVID - a RCT (RELOAD) 2021/22 Germany

Discussion in 'Long Covid research' started by Sly Saint, Dec 30, 2021.

  1. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    9,638
    Location:
    UK
    Recruitment Status : Not yet recruiting

    Sponsor:
    Schön Klinik Berchtesgadener Land
    Collaborators:
    Bavarian State Office for Health and Food Safety
    Praxis im Zentrum Erlangen
    Pneumologen Lichterfelde Berlin
    Pneumopraxis Marburg
    COVID ambulance Philipps-University Marburg
    Pneumologie Elisenhof Munich
    COVID ambulance Pneumology LMU Munich
    COVID ambulance psychology LMU Munich
    University Clinic Augsburg
    COVID ambulance Schön Klinik Schönau
    Information provided by (Responsible Party):
    Prof. Dr. Andreas Rembert Koczulla, Schön Klinik Berchtesgadener Land


    Brief Summary:
    Inpatient, multimodal rehabilitation represents one of the most important interventions in the disease management of post/long COVID. Different professional societies, including the German Society of Pneumology and the European Respiratory Society, recommend rehabilitation intervention to reduce the sequelae of COVID-19. However, from the perspective of science and practice, there are relevant areas that have been insufficiently investigated and are essential for the treatment success of post/long COVID patients:

    • Differentiation of rehabilitation effects from natural recovery after COVID-19.
    • Lack of personalized and symptom-based treatment approaches that can address the heterogeneity of symptoms in post/long COVID
    • Lack of uniform, high-quality rehabilitation standards in post-/long-COVID.
    Therefore, the primary objective of this randomized controlled trial (RCT) is to investigate whether a 3-week symptom-oriented, inpatient, multidisciplinary rehabilitation intervention, whose content focus is standardized according to cluster assignment (fatigue, cognition, soma), has a positive effect on the quality of life (primary outcome) in post-COVID syndrome patients compared to a usual care group (standard outpatient care). All study participants will be provided with a continuous telemonitoring system (SaniQ app) throughout the study period. After the interventional phase, there will be a 3 months follow-up assessment to evaluate the maintenance effects of COVID rehabilitation.

    https://clinicaltrials.gov/ct2/show/NCT05172206
     
    sebaaa, Sean, hibiscuswahine and 4 others like this.
  2. Sean

    Sean Moderator Staff Member

    Messages:
    7,605
    Location:
    Australia
    Inpatient, multimodal rehabilitation represents one of the most important interventions in the disease management of post/long COVID.

    I look forward to the evidence for that claim.

    Lack of uniform, high-quality rehabilitation standards in post-/long-COVID.

    I look forward to the evidence for that even more.

    All study participants will be provided with a continuous telemonitoring system (SaniQ app) throughout the study period. After the interventional phase, there will be a 3 months follow-up assessment to evaluate the maintenance effects of COVID rehabilitation.

    Sounds promising, though 3 months is too short, needs a minimum of a year.
     

Share This Page